Hjem › Akut myelogen leukemi › Georgia › Augusta
Kliniske studier for Akut myelogen leukemi i Augusta, GA
10 studier for Akut myelogen leukemi søker deltakere på steder i og rundt Augusta (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekruttererFase 2
- Augusta University Medical Center, Augusta
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Augusta University Medical Center, Augusta
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Augusta University Medical Center, Augusta
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Augusta University Medical Center, Augusta
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RekruttererFase 3
- Augusta University Medical Center, Augusta
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RekruttererFase 1
- Georgia Cancer Center at Augusta University, Augusta
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
RekruttererFase 2/3
- Augusta University - Georgia Cancer Center, Augusta
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruttererObservasjonsstudie
- Georgia Cancer Center at Augusta University Health, Augusta
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RekruttererFase 1
- Georgia Cancer Center at Augusta University, Augusta
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
RekruttererFase 2
- Georgia Cancer Center at Augusta University, Augusta
Akut myelogen leukemi-studier i andre byer
- Houston, TX85 studier
- New York City, NY51 studier
- Boston, MA44 studier
- Baldwin Park, CA40 studier
- Seattle, WA40 studier
- Columbus, OH35 studier
- Philadelphia, PA34 studier
- Durham, NC33 studier
- Atlanta, GA30 studier
- Tampa, FL29 studier
- Chicago, IL26 studier
- Portland, OR25 studier
Andre studier i Augusta
- Eggstokkreft8 studier
- Endometriekreft7 studier
- Kreft (alle typer)7 studier
- Sigdcelleanemi5 studier
- Brystkreft5 studier
- Myasthenia gravis4 studier
- Blodkreft4 studier
- Burkitts lymfom4 studier
- Diffust stort B-cellelymfom4 studier
- Kronisk myelogen leukemi4 studier
- Non-Hodgkins lymfom4 studier
- Livmorhalskreft4 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.